Healthcare provider profile · identity verified

Mitalee R. Dharwadkar, MD

Family Practice · MUSCATINE, IA · NPI 1437599701

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	211	61
Atorvastatin Calcium	Atorvastatin Calcium	206	81
Furosemide	Furosemide	168	54
Amlodipine Besylate	Amlodipine Besylate	163	52
Tramadol Hcl	Tramadol Hcl	159	34
Lisinopril	Lisinopril	150	60
Famotidine	Famotidine	114	40
Omeprazole	Omeprazole	109	47
Eliquis	Apixaban	108	23
Gabapentin	Gabapentin	101	33
Albuterol Sulfate Hfa	Albuterol Sulfate	90	33
Escitalopram Oxalate	Escitalopram Oxalate	87	29
Lorazepam	Lorazepam	84	21
Losartan Potassium	Losartan Potassium	83	38
Simvastatin	Simvastatin	80	33
Potassium Chloride	Potassium Chloride	78	29
Metoprolol Succinate	Metoprolol Succinate	75	30
Prednisone	Prednisone	74	42
Pregabalin	Pregabalin	69	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	22
Pantoprazole Sodium	Pantoprazole Sodium	63	26
Trazodone Hcl	Trazodone Hcl	61	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	17
Metoprolol Tartrate	Metoprolol Tartrate	60	19
Diclofenac Sodium	Diclofenac Sodium	57	14
Tamsulosin Hcl	Tamsulosin Hcl	57	26
Sertraline Hcl	Sertraline Hcl	56	19
Humalog Kwikpen U-100	Insulin Lispro	51	suppressed
Meloxicam	Meloxicam	51	23
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Clonidine Hcl	Clonidine Hcl	48	20
Montelukast Sodium	Montelukast Sodium	48	21
Metformin Hcl	Metformin Hcl	47	20
Glimepiride	Glimepiride	45	16
Alendronate Sodium	Alendronate Sodium	44	20
Duloxetine Hcl	Duloxetine Hcl	43	15
Warfarin Sodium	Warfarin Sodium	43	suppressed
Baclofen	Baclofen	42	20
Clonazepam	Clonazepam	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	21
Alprazolam	Alprazolam	41	12
Buspirone Hcl	Buspirone Hcl	41	11
Levetiracetam	Levetiracetam	41	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	41	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	11
Donepezil Hcl	Donepezil Hcl	38	suppressed
Cephalexin	Cephalexin	35	27
Ozempic	Semaglutide	34	suppressed
Atenolol	Atenolol	33	12
Clopidogrel	Clopidogrel Bisulfate	32	12
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Fluconazole	Fluconazole	31	21
Ketoconazole	Ketoconazole	31	12
Pravastatin Sodium	Pravastatin Sodium	30	14
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Nystatin	Nystatin	29	13
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	15
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Celecoxib	Celecoxib	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	14
Albuterol Sulfate	Albuterol Sulfate	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	15
Mirtazapine	Mirtazapine	22	suppressed
Finasteride	Finasteride	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Latanoprost	Latanoprost	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Azithromycin	Azithromycin	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Nucynta	Tapentadol Hcl	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Acetic Acid	Acetic Acid	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	11
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	11
Ondansetron Odt	Ondansetron	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Glipizide	Glipizide	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Nystop	Nystatin	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error